InMode to Present at Baird 2025 Global Healthcare Conference
InMode (NASDAQ:INMD), a leading provider of innovative medical technologies, has announced its participation in the upcoming Baird 2025 Global Healthcare Conference. The company's CFO Yair Malca will engage in a fireside chat on September 10, 2025, at 8:30 AM ET in New York.
The presentation will be moderated by Baird's Senior Research Analyst Jeff Johnson and will be available via live webcast. Additionally, the company will conduct one-on-one meetings with investors during the conference.
InMode (NASDAQ:INMD), fornitore leader di tecnologie mediche innovative, ha annunciato la sua partecipazione alla Baird 2025 Global Healthcare Conference. Il CFO della società, Yair Malca, parteciperà a un fireside chat il 10 settembre 2025 alle 8:30 ET a New York.
La presentazione sarà moderata dall'analista senior di Baird, Jeff Johnson, e sarà trasmessa in diretta via webcast. Inoltre, la società terrà incontri individuali con gli investitori durante la conferenza.
InMode (NASDAQ:INMD), proveedor líder de tecnologías médicas innovadoras, ha anunciado su participación en la Baird 2025 Global Healthcare Conference. El director financiero de la compañía, Yair Malca, participará en un fireside chat el 10 de septiembre de 2025 a las 8:30 AM ET en Nueva York.
La presentación estará moderada por el analista senior de Baird, Jeff Johnson, y se podrá seguir mediante webcast en directo. Además, la compañía mantendrá reuniones individuales con inversores durante la conferencia.
InMode (NASDAQ:INMD)는 혁신적인 의료 기술의 선도 업체로서 다가오는 Baird 2025 Global Healthcare Conference에 참가한다고 발표했습니다. 회사의 최고재무책임자 Yair Malca는 2025년 9월 10일 오전 8시 30분(동부시간)에 뉴욕에서 파이어사이드 챗에 참여할 예정입니다.
발표는 베어드의 수석 리서치 애널리스트인 Jeff Johnson이 사회를 맡으며, 라이브 웹캐스트로 중계됩니다. 또한 회사는 컨퍼런스 기간 동안 투자자들과 일대일 미팅도 진행할 계획입니다.
InMode (NASDAQ:INMD), un acteur de premier plan dans les technologies médicales innovantes, a annoncé sa participation à la Baird 2025 Global Healthcare Conference. Le directeur financier de la société, Yair Malca, participera à un fireside chat le 10 septembre 2025 à 8h30 ET à New York.
La présentation sera animée par l'analyste principal de Baird, Jeff Johnson, et diffusée en direct via webcast. De plus, la société tiendra des rencontres individuelles avec des investisseurs pendant la conférence.
InMode (NASDAQ:INMD), ein führender Anbieter innovativer Medizintechnologien, hat seine Teilnahme an der Baird 2025 Global Healthcare Conference angekündigt. Der CFO des Unternehmens, Yair Malca, wird am 10. September 2025 um 8:30 Uhr ET in New York an einem Fireside-Chat teilnehmen.
Die Präsentation wird von Bairds Senior Research Analyst Jeff Johnson moderiert und per Live-Webcast übertragen. Darüber hinaus wird das Unternehmen während der Konferenz Einzelgespräche mit Investoren führen.
- None.
- None.
YOKNEAM,
The fireside chat, moderated by Jeff Johnson, Senior Research Analyst, is scheduled for 8:30 am Eastern Time on Wednesday, Sept. 10, and a live webcast of the presentation can be accessed here. InMode will also hold one-on-one investor meetings in person that same day. To schedule a meeting, please contact your Baird representative.
For more information about the event, visit InMode's investor relations site here.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2025 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 04, 2025, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
Logo - https://mma.prnewswire.com/media/1064477/5329689/InMode_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/inmode-to-present-at-baird-2025-global-healthcare-conference-302541359.html
SOURCE InMode Ltd.
FAQ
When is InMode (INMD) presenting at the Baird 2025 Global Healthcare Conference?
Who will represent InMode at the Baird 2025 Healthcare Conference?
How can investors access InMode's presentation at the Baird conference?
Will InMode (INMD) be available for individual investor meetings at the Baird conference?
